MedTrace Logo

Milrinone on Right Ventricular Strain in Cardiac Surgery

NCT06077721 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2024-01-19

No results posted yet for this study

Summary

The purpose of this study is to analyze the changes in right ventricular strain before and after milrinone administration in order to find out whether milrinone improves RV systolic performance in patients undergoing cardiac surgery.

Conditions

  • Ischemic Heart Disease
  • Valvular Heart Disease

Interventions

DRUG

Milrinone

giving intravenous milrinone: 50 mcg/kg loading dose by IV push over 10 minutes, then 0.375-0.75 mcg/kg/ min infusion

Sponsors & Collaborators

  • Konkuk University Medical Center

    lead OTHER

Principal Investigators

  • Soi Lee · Konkuk University Medical Center

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-03
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06077721 on ClinicalTrials.gov